After Plunging 33.8% in 4 Weeks, Here's Why the Trend Might Reverse for Twist Bioscience ( TWST )
The heavy selling pressure might have exhausted for Twist Bioscience (TWST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend ...
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results - ARK Innovation ETF ( BATS:ARKK )
Cathie Wood-led Ark Invest executed a significant trade in Block Inc. XYZ on Tuesday. The move comes just days before the company's much-anticipated second-quarter earnings, due on Thursday, and following its high-profile addition to the S&P 500.
Cathie Wood Drops $8.3 Million On AMD And Nvidia In Monday Trading Blitz, Sells Robinhood Stock Amid 'Project Crypto' Buzz - ARK Fintech Innovation ETF ( BATS:ARKF ) , Advanced Micro Devices ( NASDAQ:AMD )
On Monday, Cathie Wood-led Ark Invest made significant trades involving Advanced Micro Devices Inc. AMD, NVIDIA Corp NVDA, and Robinhood Markets Inc HOOD. These trades highlight Ark's strategic positioning in the tech and financial sectors. ArrivedBuy shares of homes and vacation rentals for as ...
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings - Twist Bioscience ( NASDAQ:TWST )
Q3 revenue rose to $96.1 million, beating estimates and up from $81.45 million last year. Adjusted loss per share was $0.47 vs. the consensus of $0.55; gross margin improved to 53.4%. Get special access to three exclusive "Top 10 Stocks" power lists today, updated daily.
Twist Bioscience ( TWST ) Q3 Profit Surges
Twist Bioscience ( NASDAQ:TWST ) , a synthetic DNA manufacturer serving healthcare, research, and industrial sectors, reported its third quarter fiscal 2025 results on August 4, 2025. The most notable news was a swing to profitability, as the company achieved $0.33 in GAAP diluted earnings per ...
Twist Bioscience ( TWST ) Reports Q3 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of +12.96% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Cathie Wood Doubles Down On Shopify, Buys The Dip - Dumps $4.6 Million Worth Of Robinhood Stock At Peak - ARK Fintech Innovation ETF ( BATS:ARKF ) , ARK Innovation ETF ( BATS:ARKK )
Cathie Wood-led Ark Invest made notable trades on Wednesday, focusing on Shopify Inc. SHOP and Robinhood Markets Inc. HOOD.
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , Illumina ( NASDAQ:ILMN )
Cathie Wood, the founder, CEO, and CIO of Ark Invest, underscored the application of artificial intelligence in the healthcare sector by sharing new research by Mass General Brigham, citing the discovery of cancer survival using facial photograph analysis.
Cathie Wood Dumps Palantir As Stock Touches Peak Prices, Bails On Soaring Flying-Taxi Maker Archer Aviation - Archer Aviation ( NYSE:ACHR ) , ARK Fintech Innovation ETF ( BATS:ARKF )
On Tuesday, Cathie Wood's Ark Invest made significant moves by selling shares of Palantir Technologies Inc. PLTR and Archer Aviation Inc. ACHR. These trades come as both companies experience notable market activity, with Palantir hitting a new all-time high and Archer Aviation benefiting from ...
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots - Amgen ( NASDAQ:AMGN ) , Bristol-Myers Squibb ( NYSE:BMY )
The Founder, CEO, and CIO of Ark Invest, Cathie Wood, has highlighted the rising applications of artificial intelligence and how it is poised to impact not only autonomous taxi networks and humanoid robots but also the health care space.
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Quest Diagnostics ( NYSE:DGX ) , Castle Biosciences ( NASDAQ:CSTL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham cut ON Semiconductor Corporation ON price target from $57 to $50.
Twist Bioscience ( TWST ) Reports Q2 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of -17.86% and 0.95%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics
Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics are part of the Zacks top Analyst ...
Promising Genomics & Synthetic Biology Stocks to Consider in 2025
Investors interested in the Genomics and Synthetic Biology theme should consider these stocks: Twist Bioscience Corporation, Wave Life Sciences, and CRISPR Therapeutics AG.
Twist Bioscience ( TWST ) Moves 6.6% Higher: Will This Strength Last?
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday - Archer Aviation ( NYSE:ACHR ) , Accolade ( NASDAQ:ACCD )
On Friday, Feb. 28, 2025, Cathie Wood's Ark Invest made some notable trades. The most prominent among these were the purchases of Archer Aviation Inc ACHR, Recursion Pharmaceuticals Inc RXRX, Tempus AI Inc TEM, and Iridium Communications Inc IRDM.
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday - ARK Fintech Innovation ETF ( ARCA:ARKF ) , ARK Genomic Revolution ETF ( BATS:ARKG )
On Friday, Cathie Wood-led Ark Invest made significant trades involving stocks such as Iridium Communications Inc IRDM, Twist Bioscience Corp TWST, PagerDuty Inc PD, Beam Therapeutics Inc BEAM, Roku Inc ROKU, and Ibotta Inc IBTA.
Cathie Wood Offloads $17 Million Worth Of Surging Robinhood Shares, Buys Up Deere & Co Stock Despite Decline In Net Sales - Deere ( NYSE:DE ) , ARK Innovation ETF ( ARCA:ARKK )
On Thursday, Cathie Wood-led Ark Invest executed significant trades involving Robinhood Markets Inc. HOOD and Deere & Co. DE. Ark Invest sold 266,603 shares of Robinhood through ARK Innovation ETF ARKK. This decision comes as Robinhood's stock has been on an upward trajectory, with a closing ...
Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs - UiPath ( NYSE:PATH ) , Illumina ( NASDAQ:ILMN )
Ark Invest, led by Cathie Wood, made significant trades on Monday. Among the most prominent was the sale of shares in Palantir Technologies Inc. PLTR, as the stock continued its upward trajectory following impressive financial results.
Avantor Stock Declines Despite Q4 Earnings Beat, Margins Expand
Despite AVTR's stability in proprietary chemicals and specialty procurement sales, it reports an overall soft fourth-quarter performance.
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
On Friday, Cathie Wood's Ark Invest made significant trades involving a number of prominent companies such as Amazon.com Inc AMZN, Robinhood Markets Inc HOOD, Palantir Technologies Inc PLTR, and Roblox Corp RBLX, among others.
Twist Bioscience ( TWST ) Upgraded to Buy: Here's What You Should Know
Twist Bioscience (TWST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BD Stock Falls in Pre-Market Despite Q1 Earnings Beat, Gross Margin Up
BDX's overall topline in the first quarter of fiscal 2025 continues to benefit from revenue growth in all segments.
Cathie Wood Sells Palantir Shares As Rally Cools Down, Ark Invest Also Dumps Nearly $7 Million Worth Of Robinhood Stock - ARK Innovation ETF ( ARCA:ARKK )
On Wednesday, Cathie Wood-led Ark Invest made significant trades involving Palantir Technologies Inc. PLTR and Robinhood Markets Inc. HOOD. These trades occurred amid notable developments in both companies, drawing attention from investors and market analysts.
Cathie Wood-Led Ark Invest Dumps $7M Worth Of Palantir Stock Amid Searing Rally - ARK Innovation ETF ( ARCA:ARKK ) , Palantir Technologies ( NASDAQ:PLTR )
On Tuesday, Cathie Wood-led Ark Invest made notable trades, including the sale of shares in Palantir Technologies Inc PLTR. This move came as Palantir's stock surged following its impressive fourth-quarter results and optimistic future guidance.
Company News for Feb 4, 2025
Companies In The News Are: ARLP, TSN, IDXX, TWST.
Twist Bioscience ( TWST ) Reports Q1 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of 14.52% and 2.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Gene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits Research - Twist Bioscience ( NASDAQ:TWST )
New York, United States, Jan. 23, 2025 ( GLOBE NEWSWIRE ) -- Gene synthesis is a synthetic biology technique used in the laboratory to create artificial genes. In contrast to molecular cloning and polymerase chain reactions, this method uses solid-phase DNA synthesis ( PCR ) .
Here Are the 6 Largest Stock Holdings in All of Cathie Wood's ETFs Right Now
Asset management company Ark Invest offers nine different investment funds, eight of which are available as exchange-traded funds, or ETFs. They all have a different tech-related focus, such as robotics, biotechnology, or general innovation.There are other ETFs with similar specialties.
RNA Transcriptome Profiling Tests Market Expands at 14.5% CAGR, Surpassing US$ 37 Billion by 2034 | Fact.MR Report
Rockville, MD, Jan. 20, 2025 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global RNA transcriptome profiling test market is estimated to reach a valuation of US$ 9,652.2 million in 2024 and is expected to grow at a CAGR of 14.5% during ...
All You Need to Know About Twist Bioscience ( TWST ) Rating Upgrade to Buy
Twist Bioscience (TWST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Twist Bioscience ( TWST ) Surges 9.9%: Is This an Indication of Further Gains?
Twist Bioscience (TWST) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Twist Bioscience ( TWST ) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Twist Bioscience (TWST), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Is Alvotech ( ALVO ) Stock Outpacing Its Medical Peers This Year?
Here is how Alvotech (ALVO) and Twist Bioscience (TWST) have performed compared to their sector so far this year.
Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%
Ark Invest chief Cathie Wood is known for scooping up shares of innovators early in their growth stories and holding on for the long term. The idea is to get in on these players for a bargain price, and then benefit as they launch products and revenue gains momentum.
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' - Here's Why She's Not Worried About Tech Investments - ARK Genomic Revolution ETF ( BATS:ARKG ) , ARK Innovation ETF ( ARCA:ARKK )
Cathie Wood, founder and CEO of ARK Investment Management LLC, defended the future of artificial intelligence investments while highlighting Tesla Inc. TSLA as a cornerstone of technological innovation during a recent podcast appearance with SoFi's Head of Investment Strategy, Liz Thomas.
Cathie Wood Sees $400B Opportunity In Biologics - How Have Her Bets Fared? - ARK Genomic Revolution ETF ( BATS:ARKG ) , Adaptive Biotechnologies ( NASDAQ:ADPT )
Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.
Cathie Wood's Latest Tesla Dump: Ark Sells $18M Worth Of Stock - ARK Autonomous Technology & Robotics ETF ( BATS:ARKQ ) , ARK Innovation ETF ( ARCA:ARKK )
On Tuesday, Cathie Wood-led Ark Invest executed significant trades involving Tesla Inc. TSLA. The trades included the sale of Tesla shares across multiple ETFs, reflecting strategic adjustments in Ark's portfolio. Ark Invest's decision to sell Tesla shares on Tuesday was a continuation of its ...
Is Agios Pharmaceuticals ( AGIO ) Stock Outpacing Its Medical Peers This Year?
Here is how Agios Pharmaceuticals (AGIO) and Twist Bioscience (TWST) have performed compared to their sector so far this year.
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology
Westford, USA, Nov. 22, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the Global Gene Panel Market share will reach a value of USD 11.75 Billion by 2031, with a CAGR of 19.30% during the forecast period ( 2024-2031 ) .
Company News for Nov 19, 2024
Companies In The News Are: TWST, CVS, OKLO, HSIC.
Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November - CareMax ( NASDAQ:CMAX )
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining by more than 100 points on Monday. The Dow traded down 0.04% to 43,427.62 while the NASDAQ rose 0.69% to 18,809.65. The S&P 500 also rose, gaining, 0.42% to 5,895.43. Consumer discretionary shares rose by ...
Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps - Twist Bioscience ( NASDAQ:TWST )
On Monday, Twist Bioscience Corporation TWST reported a fourth-quarter loss per share of 59 cents, beating the consensus loss of 70 cents. Twist Bioscience reported fourth-quarter sales of $84.71 million, up 27% year-over-year, beating the consensus of $82.2 million and the management guidance of ...
Top Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 Earnings - Twist Bioscience ( NASDAQ:TWST )
Twist Bioscience Corporation TWST will release earnings results for its fourth quarter, before the opening bell on Monday, Nov. 18. Analysts expect the South San Francisco, California-based bank to report a quarterly loss at 69 cents per share, versus a year-ago loss of 75 cents per share.
Twist Bioscience ( TWST ) Reports Q4 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of 19.18% and 2.59%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Cyclo Therapeutics, Inc. ( CYTH ) Reports Q3 Loss, Lags Revenue Estimates
Cyclo Therapeutics (CYTH) delivered earnings and revenue surprises of -52.94% and 24.52%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
ScPharmaceuticals, Inc. ( SCPH ) Reports Q3 Loss, Lags Revenue Estimates
scPharmaceuticals (SCPH) delivered earnings and revenue surprises of -23.33% and 7.99%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
SpringWorks Therapeutics ( SWTX ) Reports Q3 Loss, Lags Revenue Estimates
SpringWorks Therapeutics (SWTX) delivered earnings and revenue surprises of 5.26% and 8.16%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Vericel Corporation ( VCEL ) Reports Q3 Loss, Tops Revenue Estimates
Vericel (VCEL) delivered earnings and revenue surprises of 60% and 4.68%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped - ARK Fintech Innovation ETF ( ARCA:ARKF )
On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. MRNA and Square Inc. SQ. Ark Invest removed 49,922 shares of Moderna Inc. MRNA from its ARK Genomic Revolution ETF ARKG on Wednesday. The trade is estimated to be worth $2.6 million, based on the latest closing ...
